newsfilter
← Latest News
GlobeNewswire·

Entasis Therapeutics Receives Acquisition Proposal from Existing Majority Stockholder Innoviva Inc.

WALTHAM, Mass., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that its Board of D